Explore the Short- and Mid-term Effects of Fespixon in Scar Cosmesis Following Cervical or Abdominal Surgery
Clinical trial NCT05271708 · COMPLETED
Trial details
- NCT number
- NCT05271708
- Sponsor
- National Defense Medical Center, Taiwan
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-05
- Primary completion
- 2022-10-17
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.